Samyang Biopharm’s NanoReady Delivers 20x mRNA Payload for Personalized Cancer Vaccines
Samyang Biopharm announced on the 20th that nonclinical study results for its proprietary gene delivery platform, "NanoReady," designed for...
Search results for "cancer vaccine"
Moderna’s Landmark mRNA Cancer Vaccine Phase 3 Success Spotlights Korean Biotech Ties
Positive late-stage clinical results for a personalized messenger RNA cancer vaccine developed by Moderna and Merck are raising expectations that...
Global Cancer Diagnoses Projected to Jump 70% to 35 Million by 2050, WHO Warns
Global cancer diagnoses are projected to surge by roughly 70% by 2050 compared to 2024 levels, according to a landmark...
Personalized Cancer Vaccine That 'Remembers Cancer' Opens New Pathways
A domestic research team has developed artificial intelligence -based personalized cancer vaccine design technology...
Why Nearly 4,000 Women Develop Liver Cancer Each Year—Even Without Heavy Drinking
Many people still assume liver cancer is primarily caused by alcohol consumption. While heavy drinking is certainly a...
Cell and Gene Therapy Advances Take Center Stage at Samsung Joint International Symposium
Leading researchers developing stem cell and extracellular vesicle therapies for sepsis, personalized mRNA vaccines for...
GC Pharma’s Homegrown mRNA Vaccine Advances to Phase 2 Trials
GC Pharma announced on the 11th that South Korea’s Ministry of Food and Drug Safety has approved its Phase 2 clinical...
Licensing Windfalls and Exports Split Performance Among Korea’s Top Drugmakers in Q2
South Korea’s five major legacy pharmaceutical companies largely extended their revenue growth in the second quarter,...
South Korea Ranks in GSK’s Global Top 10 for Clinical Research, with Over 70 Trials Underway
"South Korea is among the top 10 markets in GSK’s global clinical research. More than 70 clinical programs are...
Fueling the Future of Biohealth: InterBiz Forum Opens in Jeju With a Record 1,500 Tech Deals
The 24th InterBiz Bio Partnering & Investment Forum 2026, a premier biohealth technology deal-making event, opened...